{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T06:13:11Z","timestamp":1790057591997,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Joongbu University Research & Development Fund"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.clinre.2016.07.001","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T17:23:06Z","timestamp":1471886586000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Non-alcoholic fatty liver disease and flavonoids: Current perspectives"],"prefix":"10.1016","volume":"41","author":[{"given":"Jung Hee","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hye","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2016.07.001_bib0005","first-page":"288","article-title":"Association between non-alcoholic fatty liver disease and liver function\/injury markers with metabolic syndrome components in class III obese individuals","volume":"58","author":"Chaves","year":"2012","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.clinre.2016.07.001_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1743-7075-8-65","article-title":"The intake of high fat diet with different trans fatty acid levels differentially induces oxidative stress and non alcoholic fatty liver disease (NAFLD) in rats","volume":"8","author":"Dhibi","year":"2011","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.clinre.2016.07.001_bib0015","first-page":"335","article-title":"Effects of soybean isoflavone on liver lipid metabolism in nonalcoholic fatty liver rats","volume":"45","author":"Leng L1","year":"2011","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/j.clinre.2016.07.001_bib0020","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.clinbiochem.2011.09.017","article-title":"Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis","volume":"44","author":"Uysal","year":"2011","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinre.2016.07.001_bib0025","first-page":"9072","article-title":"Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?","volume":"20","author":"Firneisz","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0030","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/hep.23270","article-title":"Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial","volume":"51","author":"Ratziu","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2016.07.001_bib0035","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMc1006581","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"363","author":"Violi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2016.07.001_bib0040","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clinre.2014.02.008","article-title":"Pediatric non-alcoholic fatty liver disease: recent advances","volume":"38","author":"Della Corte","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.fct.2013.07.048","article-title":"The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease","volume":"60","author":"Jung","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0050","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1309\/6VJ4DWGYDU0XYJ8Q","article-title":"Correlation of serum TNF-alpha levels and histologic liver injury scores in pediatric nonalcoholic fatty liver disease","volume":"127","author":"Manco","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clinre.2012.07.005","article-title":"Non-alcoholic steatohepatitis in morbidly obese patients","volume":"37","author":"Tran","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0060","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/00365520802588133","article-title":"Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol","volume":"44","author":"Yasutake","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0065","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2010.05.037","article-title":"Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity","volume":"54","author":"Simonen","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0070","first-page":"27","article-title":"Nonalcoholic fatty liver disease (NAFLD): a comprehensive review","volume":"36","author":"Salt","year":"2004","journal-title":"J Insur Med"},{"key":"10.1016\/j.clinre.2016.07.001_bib0075","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","article-title":"Protein sensors for membrane sterols","volume":"124","author":"Goldstein","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.clinre.2016.07.001_bib0080","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.3748\/wjg.v13.i37.4974","article-title":"Alcohol-induced steatosis in liver cells","volume":"13","author":"Donohue","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0085","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1440-1746.2011.06704.x","article-title":"SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH","volume":"26","author":"Van Rooyen","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0090","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2011.06.040","article-title":"Hepatic free cholesterol accumulates in obese, diabetic mice and causes nonalcoholic steatohepatitis","volume":"141","author":"Van Rooyen","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2016.07.001_bib0095","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/db11-0944","article-title":"miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets","volume":"61","author":"Wijesekara","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.clinre.2016.07.001_bib0100","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000340037","article-title":"Relationship between changes in plasma adiponectin concentration and insulin sensitivity after niacin therapy","volume":"2","author":"Fraterrigo","year":"2012","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.clinre.2016.07.001_bib0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jhep.2005.11.030","article-title":"Insulin resistance, adiponectin, cytokines in NASH: which is the best target to treat?","volume":"44","author":"Larter","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/MOL.0b013e3282ff5e55","article-title":"Hepatic triglyceride synthesis and nonalcoholic fatty liver disease","volume":"19","author":"Choi","year":"2008","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0115","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/01.mcg.0000212608.59090.08","article-title":"Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD)","volume":"40","author":"Madan","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0120","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jhep.2012.08.018","article-title":"CYP2E1 and oxidant stress in alcoholic and non-alcoholic Fatty Liver Disease","volume":"58","author":"Leung","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0125","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1016\/S0024-3205(01)01417-5","article-title":"Modulation of heme oxygenase in tissue injury and its implication in protection against gastrointestinal diseases","volume":"69","author":"Guo","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.clinre.2016.07.001_bib0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3797\/scipharm.1104-21","article-title":"Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: relationship to lipid profile, oxidative stress and pro-inflammatory cytokines","volume":"79","author":"Shams","year":"2011","journal-title":"Sci Pharm"},{"key":"10.1016\/j.clinre.2016.07.001_bib0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/mnfr.201300522","article-title":"Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds","volume":"58","author":"Pan","year":"2014","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.clinre.2016.07.001_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2014.06.011","article-title":"Influence of flavonoid-rich fruit and vegetable intake on diabetic retinopathy and diabetes-related biomarkers","author":"Mahoney","year":"2014","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.clinre.2016.07.001_bib0145","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s11418-013-0760-5","article-title":"Anti-allergic effects of enzymatically modified isoquercitrin (\u03b1-oligoglucosyl quercetin 3-O-glucoside), quercetin 3-O-glucoside, \u03b1-oligoglucosyl rutin, and quercetin, when administered orally to mice","volume":"67","author":"Makino","year":"2013","journal-title":"J Nat Med"},{"key":"10.1016\/j.clinre.2016.07.001_bib0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/2225-4110.110411","article-title":"Recent advances in the herbal treatment of non-alcoholic fatty liver disease","volume":"3","author":"Xiao","year":"2013","journal-title":"J Tradit Complement Med"},{"key":"10.1016\/j.clinre.2016.07.001_bib0155","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","article-title":"Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3K\/Akt\/FoxO1, and NF-kappa B pathways","volume":"53","author":"Xiao","year":"2014","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.clinre.2016.07.001_bib0160","first-page":"646","article-title":"Epigallocatechin gallate induces apoptosis in human hepatocellular carcinoma HepG2 cells via TGF\/Smad signaling pathway","volume":"31","author":"Tong","year":"2009","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.clinre.2016.07.001_bib0165","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/jcb.24763","article-title":"Protective action of liraglutide in beta cells under lipotoxic stress via PI3K\/Akt\/FoxO1 pathway","volume":"115","author":"Shao","year":"2014","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.clinre.2016.07.001_bib0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3945\/jn.111.148544","article-title":"Green tea extract suppresses NF\u03baB activation and inflammatory responses in diet-induced obese rats with nonalcoholic steatohepatitis","volume":"142","author":"Park","year":"2012","journal-title":"J Nutr"},{"key":"10.1016\/j.clinre.2016.07.001_bib0175","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0006-2952(99)00296-8","article-title":"Oxidative stress and nuclear factor-kappaB activation: a reassessment of the evidence in the light of recent discoveries","volume":"59","author":"Bowie","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0180","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.canlet.2013.08.031","article-title":"Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions","volume":"342","author":"Kochi","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clinre.2016.07.001_bib0185","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jn\/138.2.323","article-title":"Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury","volume":"138","author":"Bruno","year":"2008","journal-title":"J Nutr"},{"key":"10.1016\/j.clinre.2016.07.001_bib0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.tiv.2014.01.006","article-title":"Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats","volume":"28","author":"Bellaver","year":"2014","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.clinre.2016.07.001_bib0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.cmet.2014.04.018","article-title":"Resveratrol prevents high fat\/sucrose diet-induced central arterial wall inflammation and stiffening in nonhuman primates","volume":"20","author":"Mattison","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.clinre.2016.07.001_bib0200","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0024-3205(99)00410-5","article-title":"Biological effects of resveratrol","volume":"66","author":"Fr\u00e9mont","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.clinre.2016.07.001_bib0205","doi-asserted-by":"crossref","first-page":"7366","DOI":"10.3748\/wjg.v20.i23.7366","article-title":"Effects of resveratrol and other polyphenols in hepatic steatosis","volume":"20","author":"Aguirre","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0210","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.nut.2013.11.016","article-title":"Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation","volume":"30","author":"Andrade","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/j.clinre.2016.07.001_bib0215","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-8-40","article-title":"Resveratrol inhibits nonalcoholic fatty liver disease in rats","volume":"8","author":"Bujanda","year":"2008","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0220","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.freeradbiomed.2004.06.033","article-title":"Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease","volume":"37","author":"Videla","year":"2004","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.clinre.2016.07.001_bib0225","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1155\/2011\/525094","article-title":"Distinct effects of calorie restriction and resveratrol on diet-induced obesity and Fatty liver formation","volume":"2011","author":"Tauriainen","year":"2011","journal-title":"J Nutr Metab"},{"key":"10.1016\/j.clinre.2016.07.001_bib0230","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jhep.2008.08.012","article-title":"Dietary resveratrol alters lipid metabolism-related gene expression of mice on an atherogenic diet","volume":"49","author":"Ahn","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0235","doi-asserted-by":"crossref","first-page":"19279","DOI":"10.1074\/jbc.M114.570044","article-title":"Hypoxia-inducible lipid droplet-associated (HILPDA) is a novel peroxisome proliferator-activated receptor (PPAR) target involved in hepatic triglyceride secretion","volume":"289","author":"Mattijssen","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clinre.2016.07.001_bib0240","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1021\/jf501950s","article-title":"Anthocyanins. Plant pigments and beyond","volume":"62","author":"Santos-Buelga","year":"2014","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.clinre.2016.07.001_bib0245","doi-asserted-by":"crossref","first-page":"10370","DOI":"10.3390\/molecules190710370","article-title":"Variation in the bioactive compound content at three ripening stages of strawberry fruit","volume":"19","author":"Vo\u0107a","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.clinre.2016.07.001_bib0250","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.nutres.2011.09.026","article-title":"Purple sweet potato anthocyanins attenuate hepatic lipid accumulation through activating adenosine monophosphate-activated protein kinase in human HepG2 cells and obese mice","volume":"31","author":"Hwang","year":"2011","journal-title":"Nutr Res"},{"key":"10.1016\/j.clinre.2016.07.001_bib0255","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1021\/jf300005v","article-title":"Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways","volume":"60","author":"Shih","year":"2012","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.clinre.2016.07.001_bib0260","doi-asserted-by":"crossref","first-page":"9427","DOI":"10.1021\/jf071933i","article-title":"Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis","volume":"55","author":"Shih","year":"2007","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.clinre.2016.07.001_bib0265","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1194\/jlr.M013375","article-title":"Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKC\u03b6","volume":"52","author":"Guo","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/j.clinre.2016.07.001_bib0270","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2156-15-76","article-title":"Evolutionary study of the isoflavonoid pathway based on multiple copies analysis in soybean","volume":"15","author":"Chu","year":"2014","journal-title":"BMC Genet"},{"key":"10.1016\/j.clinre.2016.07.001_bib0275","first-page":"127","article-title":"In vitro effects of genistein and daidzein affect in vitro steroidogenesis but not gene expression of steroidogenic enzymes in adrenals of pigs","volume":"65","author":"Kaminska","year":"2014","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0280","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.foodchem.2013.12.066","article-title":"Isoflavones profiling of soybean [Glycine max (L.) Merrill] germplasms and their correlations with metabolic pathways","volume":"153","author":"Kim","year":"2014","journal-title":"Food Chem"},{"key":"10.1016\/j.clinre.2016.07.001_bib0285","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/1535370214527902","article-title":"Dietary soy isoflavones increased hepatic protein disulfide isomerase content and suppressed its enzymatic activity in rats","volume":"239","author":"Xiao","year":"2014","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.clinre.2016.07.001_bib0290","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ceb.2009.01.019","article-title":"Protein kinase C intervention: the state of play","volume":"21","author":"Roffey","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.clinre.2016.07.001_bib0295","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12263-013-0373-3","article-title":"Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats","volume":"9","author":"Xiao","year":"2014","journal-title":"Genes Nutr"},{"key":"10.1016\/j.clinre.2016.07.001_bib0300","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diabetes.54.6.1706","article-title":"The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform","volume":"54","author":"Medina-Gomez","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.clinre.2016.07.001_bib0305","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1748-1716.2007.01786.x","article-title":"RNAi screens reveal novel metabolic regulators: RIP140, MAP4k4 and the lipid droplet associated fat specific protein (FSP) 27","volume":"192","author":"Puri","year":"2008","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.clinre.2016.07.001_bib0310","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1753-0407.2009.00045.x","article-title":"Genistein improves liver function and attenuates non-alcoholic fatty liver disease in a rat model of insulin resistance","volume":"1","author":"Mohamed Salih","year":"2009","journal-title":"J Diabetes"},{"key":"10.1016\/j.clinre.2016.07.001_bib0315","first-page":"483","article-title":"Soy protein and genistein improves renal antioxidant status in experimental nephrotic syndrome","volume":"34","author":"Javanbakht","year":"2014","journal-title":"Nefrologia"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740116301000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740116301000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:25:49Z","timestamp":1761895549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740116301000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2210740116301000"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2016.07.001","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease and flavonoids: Current perspectives","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2016.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}